SI-BONE, Inc. (SIBN) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, SI-BONE, Inc.'s filing signal turned positive.

SI-BONE, Inc. is a medical device company specializing in innovative procedural solutions for compromised bone, with a particular focus on minimally invasive treatments for sacroiliac joint dysfunction and degeneration. Leveraging its expertise in biomechanical design and 3D printing, the company has expanded its technology platform to address thoracolumbar fixation and fusion, as well as pelvic trauma. SI-BONE markets its patented titanium implants and associated instruments primarily through a direct sales force in the United States and a combination of direct sales and third-party agents internationally. As of December 31, 2025, over 140,000 procedures have been performed using its products since the launch of its first iFuse implant in 2009.

Revenue is primarily driven by the volume of surgical procedures performed using the company's implants and instruments, influenced by factors such as physician adoption, market penetration, and reimbursement rates.